Borderline personality disorder and persistently elevated levels of risk in 36-month outcomes for the treatment of heroin dependence

Addiction

Volumn 102, Issue 7, 2007, Pages 1140-1146

  Darke, Shane ^a   Ross, Joanne ^a   Williamson, Anna ^a   Mills, Katherine L ^a   Havard, Alys ^a   Teesson, Maree ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Borderline personality disorder; Heroin; Outcome; Risk; Treatment

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; BORDERLINE STATE; CRIME; DRUG OVERDOSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH; MULTIPLE DRUG ABUSE; RISK; SUICIDE ATTEMPT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AUSTRALIA; BORDERLINE PERSONALITY DISORDER; COHORT STUDIES; CRIME; FEMALE; FOLLOW-UP STUDIES; HEROIN DEPENDENCE; HUMANS; MALE; MIDDLE AGED; NEEDLE SHARING; OVERDOSE; RISK FACTORS; SUICIDE, ATTEMPTED; TREATMENT OUTCOME;

EID: 34250320872     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2007.01876.x     Document Type: Article

References (27)

1. Seivewright N., Daly C. Personality disorder and drug use: a review. Drug Alcohol Rev 1997 16 : 235 60.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn text revision. Washington, DC : American Psychiatric Association 2000.
3. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Geneva : World Health Organization 1993.
4. Darke S., Williamson A., Ross J., Teesson M., Lynskey M. Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend 2004 74 : 77 83.
5. Trull T. J., Sher K. J., Minks-Brown C., Durbin J., Burr R. Borderline personality disorder and substance use disorders: a review and integration. Clin Psych Rev 2000 20 : 235 53.
6. Brodskey B., Malone K., Ellis S., Dulit R. A., Mann J. J. Characteristics of borderline personality disorder associated with suicidal behavior. Am J Psychiatry 1997 154 : 1715 9.
7. Gutpa B., Trzepacz P. T. Serious overdosers admitted a general hospital: comparison with nonoverdose self-injuries and medically ill patients with suicidal ideation. Gen Hosp Psychiatry 1997 19 : 209 15.
8. Mann J. J., Waternaux C., Grethen L., Malone K. Towards a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry 1999 156 : 181 9.
9. Schaar I., Ojehagan A. Severely ill substance abusers: an 18-month follow-up study. Soc Psychiatry Psychiatr Epidemiol 2001 36 : 70 8.
10. Uchida H., Watanabe K., Suzuki T., Goto A., Kashima H. Two case reports of successful prevention of overdosing in borderline patients. Psychiatry 2005 68 : 179 83.
11. Van den Bosch L., Verhaul R., van den Brink W. Substance abuse in borderline personality disorder: clinical and etiological correlates. J Pers Disord 2001 15 : 416 24.
12. Darke S., Ross J., Williamson A., Teesson. M. The impact of borderline personality disorder on 12 month outcomes for the treatment of heroin dependence. Addiction 2005 100 : 1121 30.
13. Darke S., Hall W., Heather N., Wodak A., Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opioid users. The Opiate Treatment Index. Br J Addict 1992 87 : 593 602.
14. Ware J. E., Kosinski M., Keller S. D. A 12-item Short-Form health survey: construction of scales, and preliminary tests of reliability and validity. Med Care 1996 34 : 220 33.
15. World Health Organization. Composite International Diagnostic Interview, version 1.1. Geneva : World Health Organization 1993.
16. Andrews G., Hall W., Teesson M., Henderson S. The Mental Health of Australians: National Survey of Mental Health and Wellbeing. Canberra : Commonwealth Department of Health and Aged Care 1999.
17. SPSS, Inc. SPSS for Windows, version 14.0. Chicago, IL : SPSS Inc. 2005
18. Darke S., Degenhardt L., Mattick R. Mortality Amongst Illicit Drug Users: Epidemiology, Causes and Intervention. Cambridge : Cambridge University Press 2007.
19. Darke S., Ross J., Williamson A., Mills K. L., Havard A., Teesson M. Patterns and correlates of attempted suicide by heroin users over a three year period: findings from the Australian Treatment Outcome Study. Drug Alcohol Depend 2007 87 : 146 52.
20. Darke S., Ross J., Teesson M., Ali R., Cooke R., Ritter A., Lynskey M. Factors associated with 12 months continuous heroin abstinence: findings from the Australian Treatment Outcome Study (ATOS). J Subst Abuse Treat 2005 28 : 255 63.
21. Gossop M., Marsden J., Stewart D., Rolfe A. Treatment retention and 1 year outcomes for residential programmes in England. Drug Alcohol Depend 1999 57 : 89 98.
22. Bateman A., Fogarty P. Treatment of borderline personality disorder with psychoanalytically oriented partial hopitalization: an 18-month follow-up. Am J Psychiatry 2001 156 : 36 42.
23. Lineahan M., Dimeff S. K., Reynolds K. A., Comtois S. S., Welch P., Heagarty D. R. et al. Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug Alcohol Depend 2002 67 : 13 26.
24. Osborne I. L., McCormish J. F. Working with borderline personality disorder: nursing interventions using dialectical behavioral therapy. J Psychosoc Nurs Ment Health Serv 2006 44 : 40 7.
25. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend 1998 51 : 253 63.
26. Jackson C. T., Covell N. H., Frisman L. K., Essock S. M. Validity of self-reported drug use among people with co-occurring mental health and substance use disorders. J Dual Diagn 2004 1 : 49 63.
27. Welp E. A. E., Bosman I., Langedam M. W., Totte M., Maes R. A. A., van Ameijden E. J. C. Amount of self-reported illicit drug use compared to quantitative hair test results in community-recruited young drug users in Amsterdam. Addiction 2003 98 : 987 94.